MRHC Partners with Surfacide Helios® System To Strengthen Disinfection Efforts
June 25, 2021 1:13 pm
Magnolia Regional Health Center (MRHC) has partnered with Surfacide to continue to remain on the forefront of innovation and infection control, as it has begun utilizing the Surfacide Helios® System throughout the organization.
Throughout healthcare, and specifically during the COVID-19 pandemic, environmental services staff members play a vital role in keeping patients, visitors and staff safe at all times. In their efforts in doing so, many disinfectant cleaning products are utilized to ensure patient rooms and frequented areas throughout the facility are cleaned to protect against infectious disease threats, including COVID-19 and many others. The newly acquired Surfacide Helios® System will help with disinfectant efforts at MRHC for years to come.
“We’re excited to implement the Surfacide system within our facility and utilize its capabilities to ensure that our patients continue to receive care in the safest and cleanest environment possible,” said Jim Hobson, Chief Executive Officer at MRHC. “Throughout the pandemic, substantial fear of acquiring the COVID-19 virus has negatively impacted the thoughts of visiting the hospital amongst our patient base and patients’ willingness to visit the hospital for necessary care and services. By continuing to partner with the most innovative partners in healthcare, such as Surfacide, we remain confident in our ability to protect all who enter our doors.”
So how does it work? UV technology destroys the genetic bonds in pathogens rendering them unable to replicate and cause infection. UV light only works on directly exposed surfaces in proximity. According to the Food and Drug Administration (FDA), “UVC radiation is a known disinfectant for air, water, and nonporous surfaces. UVC radiation has effectively been used for decades to reduce the spread of bacteria, such as tuberculosis.” 
According to studies, Surfacide UV-C is scientifically proven to reduce Coronavirus on hard surfaces. Surfacide’s efficacy is proven against MERS-CoV, a similar strain of coronavirus to SARS-CoV-2, the causative agent of COVID-19. Surfacide delivers more UV-C energy to more surfaces and positions multiple emitters closer to high-touch surfaces and reduces shadowed areas, delivering more energy to more surfaces throughout your space in a single cycle. Surfacide calculates cycle time dose according to your space, and emitters laser map your space to calculate the most effective UV-C dose and rapidly decontaminates the area, reducing overall time and labor.
“MRHC has always prided itself on providing the highest quality environment for our patients, guests and staff members,” said Terry Plunk, Executive Director of Support Services at MRHC. “Our EVS staff works hard daily to clean areas and surfaces, and Surfacide will allow them to continue to do so with its ease of use and technology.”
Plunk added, “I’m most proud for our patients who can confidently know that our team is doing our absolute best and utilizing the most state-of-the-art methods to provide a safe and comfortable atmosphere during their visit.”
About Surfacide Helios® System
Surfacide was founded in 2010 and its Helios® System is the world’s only patented, triple emitter ‘robotic’ UV-C light solution to rapidly eliminate and prevent the spread of deadly pathogens. Made and manufactured in Waukesha, WI, Surfacide is proud to deliver its scientifically proven, hospital grade UV-C technology to the world now more than ever.
A trusted partner in infection prevention, Surfacide has been deployed in over 500 leading hospitals, nursing homes, dental offices, fire stations, prisons, police stations, commercial office spaces, hotels and public venues worldwide. For more information, please visit www.surfacide.com.
This post was written by Magnolia Regional Health Center
